WeVote
Log In

Bill

Bill

HB 145

Diabetes Research Institute/UNC-Chapel Hill/Funds.

2025-2026 Session Introduced by Mary Belk and 29 co-sponsors

One-time $50M General Fund to UNC System for UNC-Chapel Hill to establish a diabetes research institute, effective July 1, 2025 (FY2025-26).

Passed 1st Reading
#appropriations;boards;budgeting;colleges&universities;counties;diseases&healthdisorders;education;highereducation;municipalities;public;publichealth;unc;uncboardofgovernors;chapelhill;orangecounty
0
WeVote Research Nonpartisan
Bill Summary · HB 145

Summary — HB 145 (North Carolina): Funds for Diabetes Research Institute at UNC–Chapel Hill

Main purpose

Appropriate one-time state funds to establish a diabetes research institute at the University of North Carolina at Chapel Hill (UNC‑CH). The bill provides a nonrecurring General Fund appropriation to the UNC System Board of Governors to allocate to UNC‑CH for development of the institute.

Key provisions

  • Appropriation: $50,000,000 (fifty million dollars) in nonrecurring General Fund money for the 2025–2026 fiscal year.
  • Recipient/administration: Funds are appropriated to the Board of Governors of The University of North Carolina to be allocated to UNC‑Chapel Hill.
  • Purpose: To develop a diabetes research institute at UNC‑CH. The statutory text does not specify line‑item uses (e.g., capital vs. operating), allocation breakdown, or additional oversight/reporting requirements.
  • Effective date: The act becomes effective July 1, 2025.

Who is affected

  • UNC System Board of Governors: receives the appropriation and is responsible for allocation.
  • UNC‑Chapel Hill: primary beneficiary; will use the funding to plan/establish the diabetes research institute (staffing, facilities, equipment, program development, etc., as determined by the campus).
  • Patients, clinicians, researchers, and the regional economy (Chapel Hill / Orange County): likely indirect beneficiaries through expanded research capacity, potential clinical programs, grant attraction, and economic activity.
  • State budget/taxpayers: one‑time $50M General Fund expenditure in FY 2025–26.

Fiscal and policy notes

  • Fiscal impact: a one‑time $50M General Fund outlay in 2025–26. The bill does not appropriate recurring funds or specify future operating cost coverage; ongoing costs beyond the nonrecurring appropriation are not addressed.
  • Potential effects: could increase UNC‑CH research capacity, help leverage federal/private research funding, and produce local economic and health benefits. Absent additional detail, the appropriation may be used for capital improvements, equipment, seed research funding, or organizational start‑up costs as determined by UNC.

Procedural / timeline aspects

  • Introduced and first read in the North Carolina House in February 2025 (filed Feb 17; referred Feb 21, 2025 in available version).
  • Status (as reported in the provided materials): Passed first reading and referred to Appropriations (subsequent steps depend on committee action and final enactment).
  • If enacted as printed, the effective date is July 1, 2025 and funds are available for the 2025–2026 fiscal year only.

Sponsors

Primary sponsors listed include Representatives Lowery, Rhyne, Campbell, and Buansi.

Notes: The bill text is concise and narrowly focused on the appropriation and the effective date; it does not include programmatic detail, reporting requirements, or restrictions on how the Board of Governors must allocate the $50M to UNC‑CH. Stakeholders (legislative appropriations committees, UNC administration, and local partners) would typically clarify use and oversight during committee review or implementation.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.